Klaus Mörike

2.3k citations

65 papers · 1.6k indexed · h-index 22

Impact in

Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes

Papers in

Pharmacology 17
- Pharmacogenetics and Drug Metabolism 14
- Antibiotics Pharmacokinetics and Efficacy 5
Family Practice 3

Co-authors: Michel Eichelbaum Ulrich Klotz Matthias Schwab Shaojun Shi Urs Meyer Christoph H. Gleiter Richard Fux Dirk Moßhammer
Journals: British Journal of Clinical Pharmacology (5 papers)Clinical Pharmacology & Therapeutics (4 papers)European Journal of Clinical Pharmacology (3 papers)The Journal of Clinical Pharmacology (3 papers)Journal of Internal Medicine (2 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Klaus Mörike

62 papers receiving 1.6k citations

Peers

Countries citing papers authored by Klaus Mörike

Since Specialization

Citations

This map shows the geographic impact of Klaus Mörike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Mörike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Mörike more than expected).

Fields of papers citing papers by Klaus Mörike

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Mörike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Mörike. The network helps show where Klaus Mörike may publish in the future.

Co-authors

The 25 scholars most cited alongside Klaus Mörike, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Klaus Mörike Line = papers co-authored together Klaus Mörike links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Difficulties in adressing purging behaviour in the treatment of a patient with Anorexia nervosa - case 7/2013. DMW - Deutsche Medizinische Wochenschrift ·Katharina Keifenheim, Kefan Wu, Elisabeth J. Leehr, Sandra Becker, Klaus Mörike, Stephan Zipfel, Martin Teufel	2013	1
2	Pharmacogenetics of antimalarial drugs: effect on metabolism and transport The Lancet Infectious Diseases ·Reinhold Kerb, Richard Fux, Klaus Mörike, Peter G. Kremsner, José Pedro Gil, Christoph H. Gleiter, Matthias Schwab	2009	97
3	Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings Family Practice ·Dirk Moßhammer, I. Kleerekoper, Raissa Dinanga Malu, O. V. Belousov, Rainer Muche, Klaus Mörike	2009	11
4	Unerwünschte Arzneimittelwirkungen von Antibiotika – eine differenzialdiagnostische Herausforderung DMW - Deutsche Medizinische Wochenschrift ·Richard Fux, Klaus Mörike, C H Gleiter	2008	3
5	The clinical implications of ageing for rational drug therapy European Journal of Clinical Pharmacology ·Shaojun Shi, Klaus Mörike, Ulrich Klotz	2008	181
6	Multiple drug prescribing by general practitioners in a German region: implications for drug interactions and patient safety International Journal of Clinical Pharmacology and Therapeutics ·Richard Fux, Dale L. Greiner, Hideyuki Nagoaka, Klaus Mörike, C. H. Gleiter	2006	10
7	Dose‐Proportional Intraindividual Single‐ and Repeated‐Dose Pharmacokinetics of Roflumilast, an Oral, Once‐Daily Phosphodiesterase 4 Inhibitor The Journal of Clinical Pharmacology ·Thomas D. Bethke, Yongqiang Zhao, Róbert Hermann, Bernhard Hauns, Richard Fux, Klaus Mörike, Michael D. David, Dietrich Knoerzer, W Wurst, Christoph H. Gleiter	2006	75
8	Impact of genotype on adverse effects during treatment with metoprolol: A prospective clinical study Clinical Pharmacology & Therapeutics ·Richard Fux, Klaus Mörike, Diva Anisa Azzahra, U. Delabar, Matthias Schwab, Xing Hua Guan, Georg Lorenz, C. H. Gleiter, Michel Eichelbaum, Jacobsz Fp	2005	88
9	Valproic acid-associated sialadenosis of the parotid and submandibular glands: diagnostic and therapeutic aspects Acta Oto-Laryngologica ·G. R. Kalamkarov, Klaus Mörike, E. Kaiserling, McCordJoan	2004	13
10	Das Leitlinien-Clearingverfahren Asthma bronchiale - 2. Empfehlungen zu Eckpunkten für eine nationale Leitlinie Asthma bronchiale Pneumologie ·H. Thöle, H J Hartmann, Dirk Bassler, (unknown), Johannes Förster, Doug Franzen, Max Geraedts, Klaus Mörike, Mark D. Schmitz, Ricardo Scholz, 史子奈須, G. Ollenschläger	2004	0
11	Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans? British Journal of Clinical Pharmacology ·Stefan Freudenthaler, Peter Benöhr, Almut Grenz, Jinping Sun, Tillmann Schmidt, Klaus Mörike, Hartmut Oßwald, C. H. Gleiter	2003	11
12	Das Leitlinien-Clearingverfahren Asthma bronchiale - 1. Methodik und Ergebnisse der formalen Bewertung Pneumologie ·H. Thöle, Olaf Weingart, Ulrike Lampert, Dirk Bassler, Michaelle Brett Gaffney, 春岩, Doug Franzen, Max Geraedts, Claus Kroegel, Klaus Mörike, 浩芳浦川, Rembrandt D. Scholz, Francine Holguin, G. Ollenschläger	2003	5
13	Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism Pharmacogenetics ·Christofer Borén, Matthias Schwab, Ernst‐Ulrich Griese, Claudia Marx, B. Müller‐Oerlinghausen, P. S. Schönhöfer, Christoph Meisner, Christoph H. Gleiter, Michel Eichelbaum, Klaus Mörike	2002	13
14	Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients European Journal of Clinical Pharmacology ·Philipp Lohmann, M. L. Rao, Megan Ludwig, Amita Chawla, Ulrich M. Zanger, Klaus Mörike, W. Maier, M. Bagli	2001	9
15	Pharmacokinetics and pharmacodynamics of R‐ and S‐gallopamil during multiple dosing British Journal of Clinical Pharmacology ·Annette S. Gross, Michel Eichelbaum, Klaus Mörike, Gerd Mikus	2000	4
16	A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers European Journal of Clinical Pharmacology ·Dieter Schrenk, D. Brockmeier, Klaus Mörike, Karl Walter Bock, Michel Eichelbaum	1998	94
17	Dietary salt increases first-pass elimination of oral quinidine* Clinical Pharmacology & Therapeutics ·Dawood Darbar, Simonetta Dell’Orto, Klaus Mörike, G. Wilkinson, Dan M. Roden	1997	37
18	Epinephrine-induced changes in serum potassium and cardiac repolarization and effects of pretreatment with propranolol and diltiazem The American Journal of Cardiology ·Dawood Darbar, M. R. Smith, Klaus Mörike, Dan M. Roden	1996	39
19	Stereoselective inhibition of nortriptyline hydroxylation in man by quinidine Xenobiotica ·I. del V. Vinoles, Klaus Mörike, D. Winne, W. Schareck, U. Breyer-Pfaff	1992	19
20	Debrisoquine/Sparteine Hydroxylation Genotype and Phenotype: Analysis of Common Mutations and Alleles of CYP2D6 in a European Population DNA and Cell Biology ·Franck Broly, Andrea Gaedigk, Markus H. Heim, Michel Eichelbaum, Klaus Mörike, Urs Meyer	1991	186

About Klaus Mörike

Klaus Mörike is a scholar working on Pharmacology, Family Practice, Geriatrics and Gerontology, Toxicology and Pharmacology, having authored 65 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (14 papers), Pharmaceutical studies and practices (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Lipoproteins and Cardiovascular Health (4 papers), Heart Failure Treatment and Management (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). The work is most often cited by research in Pharmacology (508 citations), Geriatrics and Gerontology (196 citations), Family Practice (69 citations), Toxicology (45 citations) and Pediatrics, Perinatology and Child Health (241 citations). Klaus Mörike has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Michel Eichelbaum, Ulrich Klotz, Matthias Schwab, Shaojun Shi, Urs Meyer, Christoph H. Gleiter, Richard Fux, Dirk Moßhammer, Andrea Gaedigk and Markus H. Heim. Their work appears in journals such as British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, European Journal of Clinical Pharmacology, The Journal of Clinical Pharmacology and Journal of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact